On the toxicity of chemotherapy for breast cancer--the need for vigilance.
Erban
John K
JK
Lau
Joseph
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000378:metabolism / Q000494:pharmacology; D015415:Biomarkers / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D011237:Predictive Value of Tests; D011358:Product Surveillance, Postmarketing; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D013997:Time Factors
D015415:Biomarkers